Guobang Pharma Ltd. engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries. The company offers pharmaceutical products, including quinolones, macrolides, cephalosporins, characteristic APIs, preparations and accessories, and key pharmaceutical intermediates; and mobile protection APIs, kinetophoretic preparations, and feed additives. It sells its products approximately in 117 countries and regions worldwide. The company was founded in 1996 and is based in Xinchang, China.
Frequently asked questions
What sector does Guobang Pharma Ltd (605507) operate in?
Guobang Pharma Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Guobang Pharma Ltd (605507) current stock price?
As of the latest data, Guobang Pharma Ltd stock price is CN¥18.09, with a previous close of CN¥17.87. Guobang Pharma Ltd gained CN¥0.22 in the last trading session, representing a 1.23% increase.
What is Guobang Pharma Ltd (605507) current market capitalization?
Guobang Pharma Ltd market cap is approximately 14.15 billion.
What is Guobang Pharma Ltd (605507) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.92.
What is Guobang Pharma Ltd (605507) Price-to-Earnings (P/E) ratio?
Guobang Pharma Ltd current P/E ratio is 19.66.
Does Guobang Pharma Ltd (605507) pay dividends?
Yes. Guobang Pharma Ltd pays annual dividends with an annualized yield of 2.37% and an estimated annual payout of CN¥0.43 per share.
When is the next ex-dividend date for Guobang Pharma Ltd (605507)?
The next ex-dividend date is scheduled for May 29, 2027.
What is Guobang Pharma Ltd (605507) beta (volatility) score?
Guobang Pharma Ltd has a beta of 0.184, indicating lower volatility than the overall market.
